A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fifth Affiliated Hospital, Sun Yat-Sen University
University of Washington
University of Kentucky
Barbara Ann Karmanos Cancer Institute
University of Rochester
Washington University School of Medicine
Northwestern University